Risk factors and treatment of portal vein thrombosis after liver transplantation
10.3760/cma.j.cn113884-20220116-00022
- VernacularTitle:肝移植受者术后发生门静脉血栓的危险因素分析及治疗方式探讨
- Author:
Lixin LI
1
;
Yinjie GAO
;
Xiaofeng NIU
;
Minjuan REN
;
Zhenwen LIU
;
Hongbo WANG
Author Information
1. 解放军总医院第五医学中心肝胆外科，北京 100039
- Keywords:
Liver transplantation;
Portal vein;
Thrombosis;
Risk factors
- From:
Chinese Journal of Hepatobiliary Surgery
2022;28(10):735-739
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the risk factors and treatment of portal vein thrombosis (PVT) in patients after liver transplantation.Methods:The clinical data of 290 recipients who underwent liver transplantation at the Department of Hepatology, the Fifth Medical Center of PLA General Hospital from July 2015 to April 2019 were retrospectively analyzed. There were 245 males and 45 females, with a median age of 51(44, 56) years old. The liver transplantation recipients were divided into two groups according to whether PVT occurred or not after operation: the PVT group ( n=16) and the non-PVT group ( n=274). Gender, age and other clinical data of the recipients were compared between the two groups. Outpatient and inpatient follow-up were performed. The risk factors of postoperative PVT were analysed in the liver transplantation recipients. Results:The median follow-up of these 290 liver transplant recipients was 59(42, 73) months, and 16 patients were confirmed to have PVT after operation, with an incidence of 5.5%(16/290). Multivariate logistic regression analysis showed that preoperative PVT ( OR=12.773, 95% CI: 3.887-41.973) was an independent risk factor for PVT after liver transplantation. For the 16 patients with postoperative PVT, 10 were treated with portal vein intervention, and the remaining 6 patients were treated with oral aspirin or rivaroxaban anticoagulation due to mild symptoms. The 3-year survival rate of the PVT group was 93.8% (15/16), while that of the non-PVT group was 90.1% (247/274). There was no significant difference in the 3-year survival rates between the two groups (χ 2<0.01, P=0.969). Conclusions:Preoperative PVT in recipients was an independent risk factor for PVT after liver transplantation. For patients with postoperative PVT, appropriate treatment resulted in good results without affecting the long-term prognosis of these patients.
